Propofol is a safe and effective induction agent in pediatric anesthesia, but pharmacokinetic differences in children necessitate higher dosing.
Answers are grounded in this paper and cite their sources.
Supports higher propofol dosing in children; leaves open need for randomized trials to guide practice.
Summary Propofol has been used in paediatric anaesthesia since 1985 and an increasing body of evidence has shown that it is a safe, effective induction agent which has dose‐related side‐effects comparable with other agents. Pain on injection can be ameliorated by the use of antecubital veins or by pre‐mixing an adequate amount of lignocaine with propofol immediately prior to administration. The pharmacokinetics of propofol are different in children with their larger central compartment volume and clearance reflected in higher dose requirements for induction and maintenance of anaesthesia. This has important implications when propofol is given for sedation or anaesthesia by continuous infusion.
No takes yet. Share an insight, caveat, or question.
Morton et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: